Low level of antifungal resistance of <i>Candida glabrata</i> blood isolates in Turkey: Fluconazole minimum inhibitory concentration and <i>FKS</i> mutations can predict therapeutic failure

Abstract

Antifungal susceptibility testing should be supplemented with HS-FKS sequencing to predict TF for echinocandins, whereas fluconazole MIC ≥ 32 µg/mL may predict TF. Recent emergence of C glabrata isolates associated with antifungal TF warrants future comprehensive prospective studies in Turkey.